Association between P2Y1 and P2Y12 polymorphisms and acute myocardial infarction and ADP-induced platelet aggregation
- PMID: 36681816
- PMCID: PMC9867862
- DOI: 10.1186/s12872-023-03075-4
Association between P2Y1 and P2Y12 polymorphisms and acute myocardial infarction and ADP-induced platelet aggregation
Abstract
Background: The objective of this study was to investigate the relationship between P2Y1 and P2Y12 genotypes and the risk of acute myocardial infarction (AMI) in the Quanzhou population and to determine associations between P2Y1 and P2Y12 genotypes and ADP-induced platelet aggregation in this population.
Methods: All subjects were screened for P2Y1 (c.1622A > G) and P2Y12 (H1/H2, c.34C > T) polymorphisms by direct DNA sequencing. The maximal platelet aggregation rate (MAR) in AMI patients (n = 61) and healthy control subjects (n = 50) was measured by a PL-12 platelet function analyzer, and adenosine diphosphate (ADP) (5 μmol/L) was used as an agonist.
Results: The haploid H2 allele in the P2Y12 gene was more frequent in patients with AMI than in control subjects (OR 1.887, P = 0.005). The P2Y12 H2 haplotype was significantly associated with AMI in the codominant (P = 0.008), dominant (OR 2.103, P = 0.003), and overdominant models (OR 2.133, P = 0.003). After adjusting for potential confounders, H2 haplotype carriers had a 2.132-fold increased risk for AMI (OR 2.132, P = 0.012) compared with noncarriers. Moreover, we observed that the ADP-induced MAR in the carriers of the H2 haplotype from the control group was somewhat higher than that in noncarriers of this group (P = 0.020). However, we failed to demonstrate that the P2Y1 H1/H2 polymorphism affected ADP-induced MAR in AMI patients. Additionally, P2Y1 c.1622A > and P2Y12 c.34C > T polymorphisms were not associated with the risk of AMI or ADP-induced MAR in either group.
Conclusions: Therefore, our results suggest that the P2Y12 H2 haplotype was associated with a higher risk of AMI, while its effect on increased ADP-induced platelet aggregation remains to be investigated. Thus, the P2Y12 H2 haplotype may be a potential marker for AMI.
Keywords: Acute myocardial infarction; P2Y1 gene; P2Y12 gene; Platelet aggregation; Polymorphism.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population.Thromb Res. 2013 Aug;132(2):221-6. doi: 10.1016/j.thromres.2013.06.020. Epub 2013 Jul 10. Thromb Res. 2013. PMID: 23849096
-
Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.Platelets. 2013;24(4):297-302. doi: 10.3109/09537104.2012.693992. Epub 2012 Jun 21. Platelets. 2013. PMID: 22721490
-
P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose.Blood Coagul Fibrinolysis. 2005 Apr;16(3):199-204. doi: 10.1097/01.mbc.0000164429.21040.0a. Blood Coagul Fibrinolysis. 2005. PMID: 15795539
-
P2Y12, a new platelet ADP receptor, target of clopidogrel.Semin Vasc Med. 2003 May;3(2):113-22. doi: 10.1055/s-2003-40669. Semin Vasc Med. 2003. PMID: 15199474 Review.
-
The role of ADP receptors in platelet function.Front Biosci. 2006 May 1;11:1977-86. doi: 10.2741/1939. Front Biosci. 2006. PMID: 16368572 Review.
Cited by
-
Progress Analysis of Personalized Antiplatelet Therapy in Patients with Coronary Heart Disease Undergoing Interventional Therapy.Rev Cardiovasc Med. 2024 Dec 25;25(12):462. doi: 10.31083/j.rcm2512462. eCollection 2024 Dec. Rev Cardiovasc Med. 2024. PMID: 39742248 Free PMC article. Review.
References
-
- Priyadharsini R, Umamaheswaran G, Raja TA, Arun Kumar AS, Subraja K, Dkhar SA, Satheesh S, Adithan C, Shewade DG. Frequency of single nucleotide platelet receptor gene polymorphism (P2Y12-i744T>C) in coronary artery disease patients among Tamilian population. J Commun Genet. 2017;8(2):127–132. doi: 10.1007/s12687-017-0293-9. - DOI - PMC - PubMed
-
- Timur AA, Murugesan G, Zhang L, Aung PP, Barnard J, Wang QK, Gaussem P, Silverstein RL, Bhatt DL, Kottke-Marchant K. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol. 2012;34(5):473–483. doi: 10.1111/j.1751-553X.2012.01420.x. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases